Related references
Note: Only part of the references are listed.EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Nithya Subramanian et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
Liyu Li et al.
BIOMATERIALS (2014)
A strain-promoted alkyne-azide cycloaddition (SPAAC) reaction of a novel EpCAM aptamer-fluorescent conjugate for imaging of cancer cells
Nithya Subramanian et al.
CHEMICAL COMMUNICATIONS (2014)
Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases
Jagat R. Kanwar et al.
DRUG DISCOVERY TODAY (2014)
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form
Julie Salomon et al.
HUMAN GENETICS (2014)
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
Yanling Song et al.
ANALYTICAL CHEMISTRY (2013)
EpCAM proteolysis: new fragments with distinct functions?
Ulrike Schnell et al.
BIOSCIENCE REPORTS (2013)
RNA aptamers targeting cancer stem cell marker CD133
Sarah Shigdar et al.
CANCER LETTERS (2013)
Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
Manuel Simon et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
RNAstructure: web servers for RNA secondary structure prediction and analysis
Stanislav Bellaousov et al.
NUCLEIC ACIDS RESEARCH (2013)
A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches
John G. Bruno
PHARMACEUTICALS (2013)
Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study
Michael E. Kwiatt et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
Sandeep Singh et al.
MOLECULAR CANCER (2012)
Aptamers and Their Biological Applications
Kyung-Mi Song et al.
SENSORS (2012)
siRNA-Aptamer Chimeras on Nanoparticles: Preserving Targeting Functionality for Effective Gene Silencing
Vaishali Bagalkot et al.
ACS NANO (2011)
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
Sarah Shigdar et al.
CANCER SCIENCE (2011)
Chimeric aptamers in cancer cell-targeted drug delivery
Jagat R. Kanwar et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase
Libing Song et al.
PLOS ONE (2011)
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M. Schmidt et al.
ANNALS OF ONCOLOGY (2010)
Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
Anoma Somasunderam et al.
BIOCHEMISTRY (2010)
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun et al.
CARCINOGENESIS (2010)
Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells
Tung-Ying Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
In Vitro and Ex Vivo Selection Procedures for Identifying Potentially Therapeutic DNA and RNA Molecules
Soledad Marton et al.
MOLECULES (2010)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer
Du Wenqi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype
Barbara Gonzalez et al.
STEM CELLS (2009)
On the abundance of EpCAM on cancer stem cells
Olivier Gires et al.
NATURE REVIEWS CANCER (2009)
Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome
J. I. Semple et al.
CELL DEATH AND DIFFERENTIATION (2007)
The contributions of dsRNA structure to Dicer specificity and efficiency
A Vermeulen et al.
RNA (2005)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
EpCAM expression in retinoblastoma: A novel molecular target for therapy
S Krishnakumar et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Mfold web server for nucleic acid folding and hybridization prediction
M Zuker
NUCLEIC ACIDS RESEARCH (2003)